1 Min Read
Nov 14 (Reuters) - Fennec Pharmaceuticals Inc -
* Qtrly loss per share $0.04
* Fennec provides corporate update and announces third quarter 2016 results Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.